Immix Biopharma Inc (IMMX) Stock Price, Quote, News & History

IMMXNASDAQ
$10.42
0.292.86%
Last update: Aug 11, 1:57 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-38.50M
Investing Cash Flow (TTM)
-9.15M
Financing Cash Flow (TTM)
261.52M
Free Cash Flow (TTM)
-39.09M
Capital Expenditure (TTM)
-591.11K
Net Change in Cash (TTM)
213.87M

Analyst Trends and Forecast

4
Mar
1
May
2
Jun
1
Jul
2
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$491.47M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
3.16
Earnings Yield % (TTM)
-8.67%
Earnings Yield % (FWD)
-5.86%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.22

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$225.49M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$10.14
Close
-
Volume / Avg.
682.60K / 1.79M
Day Range
$9.92 - $10.67
52 Wk Range
1.94 - 12.14
Market Cap
$741.80M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
59
Short Interest
14.44%
Days to Cover
4.63

About

Sector
Health Care
Industry
Biotechnology
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific T...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Immix Biopharma (IMMX) stock?

A

You can purchase shares of Immix Biopharma (NASDAQ:IMMX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Immix Biopharma (IMMX) competitors?

Q

What is the forecast, or price target, for Immix Biopharma (IMMX) stock?

A

Immix Biopharma has a consensus price target of $20.67.

Q

What is the current price for Immix Biopharma (IMMX)?

A

The stock price for Immix Biopharma (NASDAQ: IMMX) is $10.42 last updated August 11, 2026 at 1:57 PM EDT.

Q

Does Immix Biopharma (IMMX) pay a dividend?

A

There are no upcoming dividends for Immix Biopharma.

Q

When is Immix Biopharma (NASDAQ:IMMX) reporting earnings?

A

Immix Biopharma does not have any upcoming earnings scheduled.

Q

Is Immix Biopharma (IMMX) going to split?

A

There is no upcoming split for Immix Biopharma.

Q

What sector and industry does Immix Biopharma (IMMX) operate in?

A

Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.